Icon

Noxafil Delayed Release tablets - (100 mg; Tablet, Delayed Release)

Posaconazole Merck
100 mg; Tablet, Delayed Release
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
None
More Than 5
More Than 5
Indicated for prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised
Yes
******* ** *** ***** ** **** **** ** **** ****** '*** (**** **, ****) *** *** ************ *********. ** ****** **** **** ******* ****** ** ******** ****. ** ** ********* ** **** **** $**** ** *** ***** ** ****** ******* ********* ***** ******* **** **********, ********* *** ******* ******* *******. ***** ******* ****** ********** **** **** ** *** *** ******.
Noxafil Delayed Release tablets Patent 1
******* ******* ***** **** ** **
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** *** *, **** ******* ***** **** ** ** ******** *** ****** *******
  1. *** **, **** : ******* ******** ***** ***** *** **** ** *** ******* ******* ******* ******* **** ******* '*** (**** **, ****)
  2. *** *, **** : ***** ***** * **** ******* ******* ** ******** ***** ** **.
  3. *** **, **** : ***** ***** **** '*** ****** ** ********* ** *******.
  4. ***** **, **** : ***** ******* **** *******. ********* ** ********** , ******* ***'* ****** ******* ***** ********** ** '*** ******. (*.* ***** **** ****)
  5. *** **, **** : **************** *** ******** *** ******** *******. *****://***.**********.***.***/**********_****/*********/****/******************.***
  6. *** *, **** : *** ****** *** ***** ******** *** *** ****** *******.
  7. *** **, **** : ***** ******** *** *******.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.